Qlife Holding AB (publ) (STO:QLIFE)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.955
-0.020 (-1.01%)
Mar 9, 2026, 5:29 PM CET
-33.05%
Market Cap 30.65M
Revenue (ttm) 324.00K
Net Income (ttm) -20.56M
Shares Out 15.68M
EPS (ttm) -1.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 49,446
Average Volume 42,389
Open 1.900
Previous Close 1.975
Day's Range 1.900 - 2.010
52-Week Range 1.205 - 5.740
Beta 0.69
RSI 41.30
Earnings Date Feb 11, 2026

About Qlife Holding AB

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer. Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2019
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol QLIFE
Full Company Profile

Financial Performance

In 2025, Qlife Holding AB's revenue was 324,000, an increase of 548.00% compared to the previous year's 50,000. Losses were -20.56 million, -63.24% less than in 2024.

Financial Statements

News

There is no news available yet.